The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCharacter Regulatory News (CCT)

Share Price Information for Character (CCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 277.00
Bid: 274.00
Ask: 280.00
Change: 0.00 (0.00%)
Spread: 6.00 (2.19%)
Open: 277.00
High: 277.00
Low: 274.00
Prev. Close: 277.00
CCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director's share dealings, Treasury shares and TVR

28 Dec 2022 07:34

RNS Number : 0485L
Character Group PLC
28 December 2022
 

 

 

Wednesday, 28 December 2022

 

 

 

The Character Group plc

Designers, developers and international distributor of branded toys, games and giftware

(the "Company")

 

Directors' share dealings

Transfer of treasury shares

and Total Voting Rights

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

The Character Group plc (AIM: CCT) announces that, as part of the arrangements with certain of the executive Directors of the Company which obliges those Directors to apply a proportion of their net cash annual bonus entitlements in the purchase of shares in the Company, 49,318 ordinary shares of 5p each in the capital of the Company held as treasury shares ("the Sale Shares") were today transferred out of treasury and sold by the Company at a price of 430p per share, being the mid-market closing price of an issued ordinary share in the capital of the Company on 23 December 2022. The Sale Shares were purchased by Mr Jon Diver, Mr Kiran Shah and Mr Joe Kissane, being Directors of the Company and Persons Discharging Managerial Responsibilities (PDMRs), from their net cash annual bonus entitlements for the financial year ended 31 August 2022. The said Directors have, accordingly, notified the Company of share transactions effected today by them respectively as follows:

 

· Mr Jon Diver, Joint Managing Director, purchased 27,733 Sale Shares at a price of 430p per share. Following this purchase, Mr Diver's interest in shares in the Company has increased to 1,284,089 Ordinary Shares, which represents approximately 6.63% of the Company's issued voting share capital.

 

· Mr Kiran Shah, Joint Managing Director and Group Finance Director, purchased 14,390 Sale Shares at a price of 430p per share. Following this purchase, Mr Shah's interest in shares in the Company has increased to 1,928,766 Ordinary Shares, which represents approximately 9.96% of the Company's issued voting share capital.

 

· Mr Joe Kissane, Managing Director of UK operations, purchased 7,195 Sale Shares at a price of 430p per share. Following this purchase, Mr Kissane's interest in shares in the Company has increased to 463,519 Ordinary Shares, which represents approximately 2.39% of the Company's issued voting share capital.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014 which is part of UK domestic law pursuant to the Market Abuse (Amendment) (EU Exit) regulations (SI 2019/310).

 

1.

Details of the persons discharging managerial responsibilities / person closely associated

a.

Name

Jon Diver, Kiran Shah and Joe Kissane

2.

Reason for the notification

a.

Position/status

Joint Managing Director/Joint Managing Director and Group Finance Director/Managing Director, UK Operations

b.

Initial notification/Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

The Character Group plc

b.

LEI

213800HY6EB8T8VWWE73

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5 pence

 

GB0008976119

b.

Nature of the transaction

Purchase of shares, pursuant to The Character Group plc's annual bonus arrangements for the 2022 financial year

c.

Price(s) and volume(s)

Name

Price(s)

Volume

Jon Diver

430p

27,733

Kiran Shah

430p

14,390

Joe Kissane

430p

7,195

d.

Aggregated information

· Aggregated volume

· Price

Not applicable.

e.

Date of the transaction

28 December 2022

f.

Place of the transaction

London Stock Exchange, AIM

 

 

Total voting rights (TVR)

Following the above transactions, the Company's issued share capital consists of 21,465,929 Ordinary Shares of which 2,100,159 are held in treasury. Therefore, the total number of Ordinary Shares carrying voting rights in Character Group is 19,365,770. This figure of 19,365,770 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the Disclosure Guidance and Transparency Rules.

 

 

 

ENQUIRIES:

The Character Group plc

Ray Smyth, Company Secretary

Office: +44 (0) 208 329 3377

Email:  info@charactergroup.plc.uk

 

Panmure Gordon

(Nominated Adviser and Joint Broker)

Atholl Tweedie, Investment Banking

Rupert Dearden/Charles Leigh-Pemberton, Corporate Broking

Tel: +44 (0) 20 7886 2500

 

Allenby Capital Limited

(Joint Broker)

Nick Athanas, Corporate Finance

Amrit Nahal, Sales & Corporate Broking

Tel: +44 (0) 20 3328 5656

 

TooleyStreet Communications Limited

(Investor and media relations)

Fiona Tooley

Tel: +44 (0) 7785 703523

Email: fiona@tooleystreet.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAXAPADDAFEA
Date   Source Headline
26th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20246:16 pmRNSTransaction in Own Shares
11th Apr 20245:23 pmRNSTransaction in Own Shares
9th Apr 20245:25 pmRNSTransaction in Own Shares
8th Apr 20245:49 pmRNSTransaction in Own Shares
4th Apr 20245:44 pmRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSExtension of & increase to Share Buyback Programme
13th Mar 20245:19 pmRNSTransaction in Own Shares
7th Mar 20245:55 pmRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20245:03 pmRNSTransaction in Own Shares
27th Feb 20245:03 pmRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20245:20 pmRNSTransaction in Own Shares
22nd Feb 20245:59 pmRNSTransaction in Own Shares
21st Feb 20245:03 pmRNSTransaction in Own Shares
19th Feb 20246:08 pmRNSTransaction in Own Shares
19th Feb 202412:07 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20246:13 pmRNSTransaction in Own Shares
14th Feb 20245:38 pmRNSTransaction in Own Shares
13th Feb 20245:49 pmRNSTransaction in Own Shares
9th Feb 20244:19 pmRNSTransaction in Own Shares
8th Feb 20245:44 pmRNSTransaction in Own Shares
7th Feb 202410:20 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSShare Buyback Programme
19th Jan 20244:41 pmRNSResult of AGM
19th Jan 20247:00 amRNSAGM Statement - Trading Update
14th Dec 202312:53 pmRNSHolding(s) in Company
14th Dec 202312:49 pmRNSHolding(s) in Company
12th Dec 20237:01 amRNSFinal Results - year ended 31 August 2023
12th Dec 20237:00 amRNSBoard Changes
23rd Oct 20234:58 pmRNSDirector/PDMR Shareholding
3rd Oct 20237:00 amRNSTrading Update
22nd Sep 20234:08 pmRNSHolding(s) in Company
20th Sep 20235:30 pmRNSHolding(s) in Company
22nd Aug 20237:00 amRNSHolding(s) in Company
31st Jul 20237:00 amRNSDirector/PDMR Shareholding
17th May 202311:32 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSHolding(s) in Company
11th May 20237:00 amRNSHalf-year Report - six months to 28 February 2023
27th Mar 20236:00 pmRNSHolding(s) in Company
20th Jan 20234:41 pmRNSResult of AGM
20th Jan 20237:00 amRNSTrading update ahead of the AGM
28th Dec 20227:34 amRNSDirector's share dealings, Treasury shares and TVR
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
22nd Dec 20227:00 amRNSAUDITED ANNUAL RESULTS -YEAR ENDED 31 AUGUST 2022
21st Oct 20221:41 pmRNSTransfer of treasury shares & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.